These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 7562048

  • 21. [Analysis of glucose metabolism in patients with esophageal cancer by PET: estimation of hexokinase activity in the tumor and usefulness for clinical assessment using 18F-fluorodeoxyglucose].
    Fukunaga T, Enomoto K, Okazumi S, Kikuchi T, Yamamoto H, Koide Y, Isono K.
    Nihon Geka Gakkai Zasshi; 1994 May; 95(5):317-25. PubMed ID: 8007937
    [Abstract] [Full Text] [Related]

  • 22. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 23. Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.
    Schröder O, Trojan J, Zeuzem S, Baum RP.
    Nuklearmedizin; 1998 Feb; 37(8):279-85. PubMed ID: 9868710
    [Abstract] [Full Text] [Related]

  • 24. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
    Lee M, Ko H, Yun M.
    Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
    [Abstract] [Full Text] [Related]

  • 25. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
    Lee JD, Yang WI, Park YN, Kim KS, Choi JS, Yun M, Ko D, Kim TS, Cho AE, Kim HM, Han KH, Im SS, Ahn YH, Choi CW, Park JH.
    J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
    Park JH, Kang JH, Lee YJ, Kim KI, Lee TS, Kim KM, Park JA, Ko YO, Yu DY, Nahm SS, Jeon TJ, Park YS, Lim SM.
    Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
    [Abstract] [Full Text] [Related]

  • 27. Metformin Promotes 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake in Hepatocellular Carcinoma Cells Through FoxO1-Mediated Downregulation of Glucose-6-Phosphatase.
    Wang Z, Kang F, Gao Y, Liu Y, Xu X, Ma X, Ma W, Yang W, Wang J.
    Mol Imaging Biol; 2018 Jun; 20(3):388-397. PubMed ID: 29256045
    [Abstract] [Full Text] [Related]

  • 28. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
    Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T, Endo K.
    Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
    [Abstract] [Full Text] [Related]

  • 29. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
    Lee JD, Yun M, Lee JM, Choi Y, Choi YH, Kim JS, Kim SJ, Kim KS, Yang WI, Park YN, Han KH, Lee WJ, Yoo N, Lim SM, Park JH.
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1621-30. PubMed ID: 15278306
    [Abstract] [Full Text] [Related]

  • 30. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
    Li YC, Yang CS, Zhou WL, Li HS, Han YJ, Wang QS, Wu HB.
    World J Gastroenterol; 2018 Jan 28; 24(4):494-503. PubMed ID: 29398870
    [Abstract] [Full Text] [Related]

  • 31. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
    Kong YH, Han CJ, Lee SD, Sohn WS, Kim MJ, Ki SS, Kim J, Jeong SH, Kim YC, Lee JO, Cheon GJ, Choi CW, Lim SM.
    Korean J Hepatol; 2004 Dec 28; 10(4):279-87. PubMed ID: 15613803
    [Abstract] [Full Text] [Related]

  • 32. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
    Shang JB, Li YH, Liu FY, Zeng QL, Wang JY, He XF, Chen Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun 28; 24(6):697-9. PubMed ID: 15201094
    [Abstract] [Full Text] [Related]

  • 33. The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
    Ferda J, Ferdová E, Baxa J, Kreuzberg B, Daum O, Třeška V, Skalický T.
    Anticancer Res; 2015 Apr 28; 35(4):2241-6. PubMed ID: 25862885
    [Abstract] [Full Text] [Related]

  • 34. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H, Gjedde A.
    J Nucl Med; 1991 Apr 28; 32(4):692-8. PubMed ID: 2013809
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
    Ahn KJ, Hwang HS, Park JH, Bang SH, Kang WJ, Yun M, Lee JD.
    J Nucl Med; 2009 Sep 28; 50(9):1525-32. PubMed ID: 19690031
    [Abstract] [Full Text] [Related]

  • 36. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H, Mineura K, Kowada M, Iida H, Murakami M, Ogawa T, Hatazawa J, Uemura K.
    No Shinkei Geka; 1996 Mar 28; 24(3):211-9. PubMed ID: 8851949
    [Abstract] [Full Text] [Related]

  • 37. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
    Wu HM, Huang SC, Choi Y, Hoh CK, Hawkins RA.
    J Nucl Med; 1995 Feb 28; 36(2):297-306. PubMed ID: 7830134
    [Abstract] [Full Text] [Related]

  • 38. Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score.
    Kawamura E, Habu D, Ohfuji S, Fukushima W, Enomoto M, Torii K, Kawabe J, Kondo K, Tamori A, Kawada N, Shiomi S.
    Hepatogastroenterology; 2008 Feb 28; 55(82-83):582-6. PubMed ID: 18613412
    [Abstract] [Full Text] [Related]

  • 39. Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using 18F-Fluorodeoxyglucose Positron Emission Tomography.
    Kawai T, Yasuchika K, Seo S, Higashi T, Ishii T, Miyauchi Y, Kojima H, Yamaoka R, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Nakamoto Y, Hatano E, Uemoto S.
    Clin Cancer Res; 2017 Mar 15; 23(6):1450-1460. PubMed ID: 27663597
    [Abstract] [Full Text] [Related]

  • 40. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.
    Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, Habu D, Takeda T, Kubo S, Ochi H.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1877-80. PubMed ID: 11419843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.